Secteur Taysha Gene Therapies, Inc.

Actions

TSHA

US8776191061

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 27/07/2026 Varia. 5j. Varia. 1 janv.
5,540 USD +0,36% Graphique intraday de Taysha Gene Therapies, Inc. -0,72% +0,73%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+0,36%-0,72%-12,62%-14,24%+0,73%+109,06%+784,28%-68,93% - 1,77 Md
-1,82%+4,80%+0,69%+16,63%+10,18%+56,71%+68,36%+214,54%+6 022,48% 57,28 Md
-0,27%+0,35%+5,48%+24,02%+37,53%+40,26%+79,88%-13,79% - 54,99 Md
-2,05%-2,14%+1,31%-22,98%-39,82%+0,75%+413,38%+339,86%+821,92% 23,18 Md
+1,97%-1,16%-0,14%-10,75%-4,32%-21,00%-13,25%-67,93% - 22,59 Md
-1,03%-1,24%+8,67%+13,77%+21,95%+19,81%-11,45%-67,81% - 20,46 Md
+1,57%+3,30%+12,10%+11,78%-5,87%+28,01%-29,07%-30,74%+59,93% 17,56 Md
-2,24%-1,56%+15,59%+7,31%+28,38%+31,81%+544,27% - - 15,67 Md
+5,29%+1,70%+14,77%+118,74%+182,04%+185,09%+333,94%+1 534,49%+726,43% 14,46 Md
+0,79%+0,50%+1,90%+24,99%+27,33%+22,39%+184,74%+235,20%+537,10% 13,92 Md
+1,24%+2,90%+7,53%+5,99%-5,34%+84,74%+175,74%+544,21%+7 250,00% 12,55 Md
-0,08%+19,37%+8,42%+16,21%+28,83%+443,39%+138,71%+29,69%+1 323,13% 12,06 Md
-3,40%+0,95%+4,20%-29,99%-15,49%-36,59%+122,35%+100,63% - 11,69 Md
-0,15%+1,91%-1,91%+30,88%+26,88%+116,84%+150,14%+186,80%+678,19% 10,96 Md
-4,06%-2,93%-6,46%-40,75%-25,07%-54,29%+579,02%+73,12%+83,29% 10,9 Md
-2,05%+2,78%+13,82%+39,14%+205,37%+462,34%+613,68%-39,64%-14,86% 8,98 Md
+0,14%-0,02%+128,47%+117,12%+80,13%+170,57%+354,23%+374,80% - 8,83 Md
-2,74%-2,23%+4,52%-20,29%+15,69%+20,90%+75,74%-7,55% - 8,42 Md
+1,64%-4,88%+29,67%+32,92%+16,37%+26,04%+332,70%+328,57% - 7,92 Md
+1,54%0,00%-1,80%-7,07%+20,29%+51,52%+20,05%+152,85% - 7,89 Md
Moyenne -0,23%+2,20%+11,71%+15,67%+30,29%+87,92%+245,87%+200,97%+1 748,76% 17,1 Md
Moyenne pondérée par Capi. -0,40%+2,14%+8,45%+15,71%+24,93%+66,36%+173,92%+181,37%+2 739,70%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TSHA
  4. Secteur Taysha Gene Therapies, Inc.